CFRA analyst Angelo Zino maintains Apple (NASDAQ:AAPL) with a Buy and raises the price target from $240 to $260.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/4/2025 | Buy → Hold | Needham | |
| 5/2/2025 | $290.00 → $275.00 | Buy | TD Cowen |
| 5/2/2025 | $217.00 | Buy → Neutral | Rosenblatt |
| 5/2/2025 | $170.62 | Hold → Underperform | Jefferies |
| 5/2/2025 | $260.00 → $245.00 | Buy | Monness Crespi & Hardt |
| 4/30/2025 | $197.00 → $173.00 | Underweight | Barclays |
| 4/30/2025 | $230.00 → $215.00 | Hold | Loop Capital |
| 4/29/2025 | $220.00 → $235.00 | Overweight | Morgan Stanley |
908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead
Access to the on-device Apple Intelligence model, large language model integration in Xcode, and an elegant new software design across Apple platforms give developers everything they need to build beautiful modern apps with speed and confidence Apple® today announced new technologies and enhancements to its developer tools to help developers create more beautiful, intelligent, and engaging app experiences across Apple platforms. A beautiful new software design brings more focus to content, and delivers more expressive and delightful experiences across iOS 26, iPadOS® 26, macOS® Tahoe 26, watchOS® 26, and tvOS® 26,1 while keeping them all instantly familiar. The Foundation Models framework
iPadOS 26 brings a new design; an entirely new powerful and intuitive windowing system; new features powered by Apple Intelligence; major enhancements to working with files, audio, and video; and more Apple® today previewed iPadOS® 26, the biggest iPadOS release ever, taking a huge leap forward and pushing the unique capabilities and versatility of iPad even further. A beautiful design brings a new look to iPad®, making the experience even more expressive and delightful. While maintaining the simplicity of iPad, iPadOS 26 introduces an entirely new powerful and intuitive windowing system with new features that help users control, organize, and switch between apps. Apple Intelligence™ beco
For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a
For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea
8-K - Apple Inc. (0000320193) (Filer)
FWP - Apple Inc. (0000320193) (Subject)
10-Q - Apple Inc. (0000320193) (Filer)
SC 13G/A - Apple Inc. (0000320193) (Subject)
SC 13G/A - Apple Inc. (0000320193) (Subject)
SC 13G/A - Apple Inc. (0000320193) (Subject)
Needham downgraded Apple from Buy to Hold
TD Cowen reiterated coverage of Apple with a rating of Buy and set a new price target of $275.00 from $290.00 previously
Jefferies downgraded Apple from Hold to Underperform and set a new price target of $170.62
4 - Apple Inc. (0000320193) (Issuer)
4 - Apple Inc. (0000320193) (Issuer)
4 - Apple Inc. (0000320193) (Issuer)